Literature DB >> 16848108

The experience with 113 patients with Kawasaki disease in Fars Province, Iran.

Ali Akbar Asadi-Pooya1, Mohammad Borzoee, Hamid Amoozgar.   

Abstract

This study was conducted to determine the epidemiology, clinical manifestations, cardiac involvements and laboratory findings of Kawasaki disease (KD) in Fars Province, Iran from January 1991 to December 2002. One hundred and thirteen patients with KD were confirmed. This syndrome occurred mostly in males (ratio=2.1:1). The most commonly affected age group was one to five years old. There was no secondary case in families, none of the patients were related and recurrence of disease was seen in only one patient. Prolonged fever and thrombocytosis were significant risk factors for developing coronary artery disease (p<0.05, respectively). Among the 10 patients with cardiac involvement, seven patients had dilated coronary arteries (>4 mm) and three patients had aneurysm of coronary artery in their first echocardiography. It has been suggested that a high index of clinical suspicion of KD could improve diagnosis and implementation of preventive treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16848108

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  7 in total

1.  Relapse of nephrotic syndrome triggered by Kawasaki disease.

Authors:  Ryo Maeda; Yukihiko Kawasaki; Shigeo Suzuki; Shinichiro Ohara; Suyama Kazuhide; Mitsuaki Hosoya
Journal:  CEN Case Rep       Date:  2017-11-15

Review 2.  The global epidemiology of Kawasaki disease: Review and future perspectives.

Authors:  Ming-Tai Lin; Mei-Hwan Wu
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

3.  Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Joon-Sung Lee
Journal:  Med Hypotheses       Date:  2007-03-06       Impact factor: 1.538

4.  Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran.

Authors:  Zainab Qazizadeh; Leila Shahbaznejad; Mohammad Reza Navaeifar; Mohammad Sadegh Rezai
Journal:  Front Pediatr       Date:  2022-02-28       Impact factor: 3.418

5.  Clinical and epidemiological characteristics of kawasaki disease.

Authors:  Ahmad Shamsizadeh; Tahereh Ziaei Kajbaf; Maryam Razavi; Bahman Cheraghian
Journal:  Jundishapur J Microbiol       Date:  2014-07-27       Impact factor: 0.747

6.  Comparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications.

Authors:  Iraj Mohammadzadeh; Somayyeh Noei; Kazem Babazadeh; Hassan Zamani; Rahim Barari-Savadkoohi; Reza Alizadeh-Navaei
Journal:  Caspian J Intern Med       Date:  2016

Review 7.  Kawasaki Disease: Global Burden and Genetic Background.

Authors:  Karim Elakabawi; Jing Lin; Fuyong Jiao; Ning Guo; Zuyi Yuan
Journal:  Cardiol Res       Date:  2020-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.